Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Root (often referred to as Root.bio) is a venture-backed biotechnology company focused on precision immunology and the discovery of therapies for autoimmune and inflammatory diseases. Co-founded by Pulitzer Prize-winning author and oncologist Siddhartha Mukherjee and Nathaniel Brooks Horwitz, the company leverages a proprietary platform to map the "root causes" of disease at the cellular and molecular levels. By integrating large-scale biological data with advanced computational models, Root aims to move beyond symptom management toward disease-modifying treatments. The company operates primarily in stealth mode but is recognized as a high-profile player in the emerging field of precision medicine for complex immune-mediated conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Root.